![Glenmark's Ryaltris nasal spray now approved in Europe for the first line treatment of allergic rhinitis in patients over 12 years of age | News Headlines, Latest News , Business and Political Glenmark's Ryaltris nasal spray now approved in Europe for the first line treatment of allergic rhinitis in patients over 12 years of age | News Headlines, Latest News , Business and Political](https://indiastatestimes.in/wp-content/uploads/2021/04/2021_4largeimg26_Apr_2021_163233727.jpg)
Glenmark's Ryaltris nasal spray now approved in Europe for the first line treatment of allergic rhinitis in patients over 12 years of age | News Headlines, Latest News , Business and Political
![Ryaltris olopatadine hydrochloride 665 mcg / mometasone furoate 25 mcg per 0.1 mL nasal spray Images - Pill Identifier Ryaltris olopatadine hydrochloride 665 mcg / mometasone furoate 25 mcg per 0.1 mL nasal spray Images - Pill Identifier](https://www.drugs.com/images/pills/custom/pill34249-1/ryaltris.png)
Ryaltris olopatadine hydrochloride 665 mcg / mometasone furoate 25 mcg per 0.1 mL nasal spray Images - Pill Identifier
![These highlights do not include all the information needed to use RYALTRIS® safely and effectively. See full prescribing information for RYALTRIS. RYALTRIS (olopatadine hydrochloride and mometasone furoate monohydrate nasal spray)Initial U.S. Approval: These highlights do not include all the information needed to use RYALTRIS® safely and effectively. See full prescribing information for RYALTRIS. RYALTRIS (olopatadine hydrochloride and mometasone furoate monohydrate nasal spray)Initial U.S. Approval:](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=Figure-A.jpg&id=727424)
These highlights do not include all the information needed to use RYALTRIS® safely and effectively. See full prescribing information for RYALTRIS. RYALTRIS (olopatadine hydrochloride and mometasone furoate monohydrate nasal spray)Initial U.S. Approval:
![Combination Product for Symptoms of Seasonal Allergic Rhinitis Approved by US FDA | Healthcare Packaging Combination Product for Symptoms of Seasonal Allergic Rhinitis Approved by US FDA | Healthcare Packaging](https://img.healthcarepackaging.com/files/base/pmmi/all/image/2022/02/Image_1.620e8e1c6cb5c.png?auto=format%2Ccompress&fit=max&q=70&w=1200)